A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
Clinical trial NCT02657434 · COMPLETED
Trial details
- NCT number
- NCT02657434
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-30
- Primary completion
- 2019-07-18
- Enrollment
- 578
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.